Interestingly, 39 of them were involved in cancer-related molecular pathways (ATXN2, AXIN1, BCL2L11, CAMK2B, CDH15, CDH17, CHUK, COL1A1, COL4A6, COL7A1, CSNK1G1, CTGF, CXCL12, CXCL6, FGF11, FGF5, FZD5, GABRA1, GNAS, GNRH2, HAPLN1, IHH, INSRR, ITGB2, LAMB2, LIFR, MAPK10, MUC1, PIK3R1, PPARGC1A, PSMA7, PTCH1, PTK7, SHC3, TCF4, TGFB2, TNFRSF14, TUBGCP2, and ZEB1). This evidence concerns the gene HAPLN1 and cancer.